Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.
Helena PlaMarta PardoÀngel J IzquierdoEsther DarderAnna CarbóElisabet MuntéSara Torres-EsquiusJudith BalmañaConcepción LázaroJoan M BrunetMaria-Pilar Barretina-GinestaPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
In our cohort, the risk of EC in BRCA1/2 carriers after RRSO is not greater than expected. Hysterectomy is not routinely recommended for these patients.